{
  "abstract": "Acute ischemic stroke (AIS) remains a leading cause of long-term disability globally. While reperfusion therapies are effective, there is a growing need for adjunct neuroprotective strategies to minimize secondary brain injury. Cytoflavin, a metabolic and antioxidant compound, has shown potential neuroprotective effects. However, its clinical efficacy remains underexplored. This systematic review and meta-analysis aim to evaluate the efficacy of Cytoflavin in AIS, focusing on neurological recovery (NIHSS), functional independence (Barthel Index), cognitive performance (MMSE), and infarct volume. A systematic search was conducted across multiple databases for studies evaluating Cytoflavin in AIS. Nine studies were included, with a combined enrollment of 3,254 participants across treatment arms (sample sizes reported per arm); the number of unique participants contributing to each pooled outcome was smaller after correcting for shared control groups and repeated-measures overlap across evaluation time points (e.g., 1,379 for NIHSS). Data were analyzed using random-effects models; where a shared control group was compared against two Cytoflavin dose arms within the same study, the control group was split proportionally between the two comparisons to avoid double-counting participants (unit-of-analysis correction). Risk of bias was assessed using Cochrane Risk of Bias tool and Newcastle-Ottawa Scale. Cytoflavin significantly improved NIHSS scores (MD = −2.63, 95% CI: −3.15 to −2.10; moderate certainty) and Barthel Index (MD = 19.29, 95% CI: 9.52 to 29.07; moderate certainty), and showed improvements of low certainty in MMSE scores (MD = +6.93, 95% CI: 1.39 to 12.47) and mRS scores (MD = −0.41, 95% CI: −0.74 to −0.09), the latter derived from continuous summary statistics for an inherently ordinal scale (see Limitations). For infarct volume, effects diverged by evaluation time point: a marginal increase was observed at Day-10 (MD = +0.17 cm3, based on a single study), while a non-significant reduction was observed at Day-21 (MD = −4.73 cm3, 95% CI: −11.41 to 1.95; very low certainty). High heterogeneity (I2 ranging from 0% to 100%) was observed across outcomes and persisted after the unit-of-analysis correction, indicating genuine clinical and methodological diversity across studies. In conclusion, cytoflavin shows promising neuroprotective effects in AIS. However, due to heterogeneity and methodological limitations, further large-scale, high-quality studies are needed to confirm its efficacy and optimize treatment protocols.\n\nSystematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251112430, identifier: CRD420251112430.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Neurology, Faculty of Medicine, University of Diponegoro, Semarang, Indonesia"
  ],
  "article_type": "systematic review",
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Retnaningsih Retnaningsih"
    },
    {
      "affs": [
        0
      ],
      "name": "Dodik Tugasworo"
    },
    {
      "affs": [
        0
      ],
      "name": "Wati Arinta Puspita"
    },
    {
      "affs": [
        0
      ],
      "name": "Chandra Elvika"
    },
    {
      "affs": [
        0
      ],
      "name": "Arrizki Azka Pratama"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/db4zbremjjerf.bib",
  "cited_by": 0,
  "doi": "10.3389/fstro.2026.1775376",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13759345/",
  "id": "db4zbremjjerf",
  "issns": [
    "2813-3056"
  ],
  "landing_url": "https://doi.org/10.3389/fstro.2026.1775376",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Systematic Review"
    ],
    [
      "openalex",
      "2808|Neuroprotection in Cerebral Ischemia"
    ]
  ],
  "openalex": "W7224750282",
  "pdf_url": "https://www.frontiersin.org/journals/stroke/articles/10.3389/fstro.2026.1775376/pdf",
  "pmcid": "PMC13759345",
  "pmid": "43031594",
  "published": "2026-10-30",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/db4zbremjjerf.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:24:00Z",
      "native_id": "PMC13759345",
      "source": "pmc",
      "url": "https://doi.org/10.3389/fstro.2026.1775376"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2808|Neuroprotection in Cerebral Ischemia",
      "subfield": "neurology"
    }
  ],
  "title": "Cytoflavin's neuroprotective effect in acute ischemic stroke: a systematic review and meta-analysis",
  "title_text": "Cytoflavin's neuroprotective effect in acute ischemic stroke: a systematic review and meta-analysis",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:24:00Z",
  "url": "https://research.draconitic.com/paper/db4zbremjjerf",
  "venue": "Frontiers in Stroke",
  "versions": []
}